Current Screening Might Miss Prostate Cancer in Transgender Women
MONDAY, July 1, 2024 (HealthDay News) — Current screening standards could miss early-stage prostate cancer in transgender women, a new study warns. Prostate cancer tests look for prostate-specific antigen (PSA), a protein produced by the small gland. Blood levels of PSA tend to be elevated in people with prostate cancer.Continue Reading